EMIS Group PLC Directorate Changes (8085X)

TIDMEMIS

RNS Number : 8085X

EMIS Group PLC

02 May 2019

2 May 2019

EMIS Group plc ("EMIS Group" or the "Company")

Directorate changes

EMIS Group, the UK leader in connected healthcare software and services, today announces the retirement of Robin Taylor and the appointment of Jennifer Byrne to the Board as an independent Non-executive Director.

Robin will retire at the conclusion of the 2019 Annual General Meeting (AGM) on 8 May 2019, after nine years of service with EMIS Group as Senior Non-executive Independent Director and Chair of its audit committee. Andy McKeon, Non-executive Director, who has been on the Board since 2013 will step up to the role of Senior Independent Director, while Kevin Boyd, Non-executive Director, will become Chair of the audit committee.

Jennifer Byrne will be formally appointed as an independent Non-executive Director immediately following the 2019 AGM on 8 May 2019, bringing her wealth of experience in the global software sector to the leadership team. She will join the EMIS Group Board's audit, remuneration and nomination committees.

Jennifer served Lockheed Martin for over twenty five years in a series of high ranking roles including Vice President of Space Systems Engineering and Technology where her staff numbered in excess of 10,000. She has extensive experience of successful delivery of large scale mission critical products, projects and systems in highly complex environments. More recently, Jennifer relocated to the UK to take on the position of Chief Operating Officer at G-Research, a quantitative research and technology company that produces predictive research and builds advanced data analytics technology.

Mike O'Leary, Chairman of EMIS Group, said: "Robin has completed nine years of service with EMIS Group and on behalf of his colleagues, I would like to thank him sincerely for his advice and continued support throughout. We wish him a long and happy retirement.

"It gives me great pleasure to welcome Jennifer Byrne to the Board. Her wealth of commercial experience and background in using technical insight to deliver challenging and technically complex engineering programmes, will complement and enhance the significant expertise we already have on the Board."

Appendix:

Full name: Jennifer Byrne

Age: 55

Current Directorships: None

Directorships held in the past five years: None

There are no further disclosures to be made in connection with Schedule Two of paragraph (g) of the AIM rules for companies in connection with this appointment.

- ENDS -

For further information, contact:

EMIS Group plc Tel: [phone]

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

   Numis Securities Limited (Nominated Adviser & Broker)      Tel: [phone] 

Oliver Hardy/Simon Willis/James Black

   MHP Communications                                                               Tel: [phone] 

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo

Notes to Editors

EMIS Group is the UK leader in connected healthcare software and services. Its solutions are widely used across every major UK healthcare setting from primary, community & acute care, to high street pharmacies. EMIS Group helps healthcare professionals in over 10,000 organisations share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

EMIS Group serves the following healthcare markets under the EMIS Health brand:

-- Primary, Community & Acute Care, as the UK leader in clinical management systems for healthcare providers and commissioners. EMIS Health products, including the flagship EMIS Web, hold over 40 million patient records and are used by more than 100,000 professionals in nearly 6,000 healthcare organisations.

-- Community Pharmacy, with the UK's single most used integrated community pharmacy and retail system.

These markets are also supported by other EMIS Group businesses:

-- under the Patient brand, the UK's leading independent provider of patient-centric medical and wellbeing information and related transactional services.

-- under the Egton brand, providing specialist ICT infrastructure, hardware and engineering services, and non-clinical software into health and social care.

-- under the Dovetail Lab brand, a health technology company developing blockchain software to facilitate the integration of healthcare data.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BOASSFFMFFUSESI

(END) Dow Jones Newswires

May 02, 2019 02:00 ET (06:00 GMT)